{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:41:32Z","timestamp":1792723292792,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10555-012-9415-3","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T05:09:32Z","timestamp":1351660172000},"page":"303-315","source":"Crossref","is-referenced-by-count":601,"title":["Stromal cells in tumor microenvironment and breast cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Yan","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan T.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"issue":"1","key":"9415_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., et al. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62(1), 10\u201329.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"9415_CR2","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget, S. (1989). The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews, 8(2), 98\u2013101.","journal-title":"Cancer Metastasis Reviews"},{"issue":"5","key":"9415_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R., et al. (2006). Fibroblasts in cancer. Nature Reviews. Cancer, 6(5), 392\u2013401.","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"9415_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2009.01.003","volume":"19","author":"A Ostman","year":"2009","unstructured":"Ostman, A., et al. (2009). Cancer-associated fibroblasts and tumor growth\u2014bystanders turning into key players. Current Opinion in Genetics and Development, 19(1), 67\u201373.","journal-title":"Current Opinion in Genetics and Development"},{"issue":"7","key":"9415_CR5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","volume":"116","author":"M Loeffler","year":"2006","unstructured":"Loeffler, M., et al. (2006). Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. The Journal of Clinical Investigation, 116(7), 1955\u20131962.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"9415_CR6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02147594","volume":"27","author":"G Gabbiani","year":"1971","unstructured":"Gabbiani, G., et al. (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia, 27(5), 549\u2013550.","journal-title":"Experientia"},{"issue":"26","key":"9415_CR7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak, H. F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine, 315(26), 1650\u20131659.","journal-title":"New England Journal of Medicine"},{"issue":"46","key":"9415_CR8","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Y Kojima","year":"2010","unstructured":"Kojima, Y., et al. (2010). Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 107(46), 20009\u201320014.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"9415_CR9","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1158\/0008-5472.CAN-06-2323","volume":"66","author":"N Moskovits","year":"2006","unstructured":"Moskovits, N., et al. (2006). p53 attenuates cancer cell migration and invasion through repression of SDF-1\/CXCL12 expression in stromal fibroblasts. Cancer Research, 66(22), 10671\u201310676.","journal-title":"Cancer Research"},{"issue":"7\u20139","key":"9415_CR10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1387\/ijdb.113362aa","volume":"55","author":"A Aboussekhra","year":"2011","unstructured":"Aboussekhra, A. (2011). Role of cancer-associated fibroblasts in breast cancer development and prognosis. International Journal of Developmental Biology, 55(7\u20139), 841\u2013849.","journal-title":"International Journal of Developmental Biology"},{"issue":"5","key":"9415_CR11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-04-3791","volume":"65","author":"H Kiaris","year":"2005","unstructured":"Kiaris, H., et al. (2005). Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Research, 65(5), 1627\u20131630.","journal-title":"Cancer Research"},{"issue":"22","key":"9415_CR12","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1093\/hmg\/ddn252","volume":"17","author":"G Trimis","year":"2008","unstructured":"Trimis, G., et al. (2008). Expression of p21waf1\/Cip1 in stromal fibroblasts of primary breast tumors. Human Molecular Genetics, 17(22), 3596\u20133600.","journal-title":"Human Molecular Genetics"},{"issue":"7267","key":"9415_CR13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature08486","volume":"461","author":"AJ Trimboli","year":"2009","unstructured":"Trimboli, A. J., et al. (2009). Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature, 461(7267), 1084\u20131091.","journal-title":"Nature"},{"issue":"4","key":"9415_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/cbt.11.4.14101","volume":"11","author":"C Trimmer","year":"2011","unstructured":"Trimmer, C., et al. (2011). Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biology & Therapy, 11(4), 383\u2013394.","journal-title":"Cancer Biology & Therapy"},{"issue":"6","key":"9415_CR15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2005.09.030","volume":"123","author":"R Hill","year":"2005","unstructured":"Hill, R., et al. (2005). Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell, 123(6), 1001\u20131011.","journal-title":"Cell"},{"issue":"4","key":"9415_CR16","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","volume":"4","author":"EL Spaeth","year":"2009","unstructured":"Spaeth, E. L., et al. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One, 4(4), e4992.","journal-title":"PLoS One"},{"issue":"2","key":"9415_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/2010\/695162","volume":"33","author":"C Jotzu","year":"2010","unstructured":"Jotzu, C., et al. (2010). Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Analytical Cellular Pathology (Amsterdam), 33(2), 61\u201379.","journal-title":"Analytical Cellular Pathology (Amsterdam)"},{"issue":"21","key":"9415_CR18","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg, E. M., et al. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Research, 67(21), 10123\u201310128.","journal-title":"Cancer Research"},{"issue":"18","key":"9415_CR19","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa, P., et al. (1990). Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proceedings of the National Academy of Sciences of the United States of America, 87(18), 7235\u20137239.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"9415_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez, N., et al. (2010). Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell, 17(2), 135\u2013147.","journal-title":"Cancer Cell"},{"issue":"8","key":"9415_CR21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4161\/cbt.7.8.6220","volume":"7","author":"I Mercier","year":"2008","unstructured":"Mercier, I., et al. (2008). Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biology & Therapy, 7(8), 1212\u20131225.","journal-title":"Cancer Biology & Therapy"},{"issue":"12","key":"9415_CR22","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","volume":"5","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto, H., et al. (2006). Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biology & Therapy, 5(12), 1640\u20131646.","journal-title":"Cancer Biology & Therapy"},{"issue":"6797","key":"9415_CR23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747\u2013752.","journal-title":"Nature"},{"issue":"3","key":"9415_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3121\/cmr.2012.1100.ps1-05","volume":"10","author":"R Haque","year":"2012","unstructured":"Haque, R., et al. (2012). PS1-05: disparities in breast cancer survival by molecular subtype and race\/ethnicity. Clinical Medicine & Research, 10(3), 145.","journal-title":"Clinical Medicine & Research"},{"issue":"1\u20132","key":"9415_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2009.825","volume":"7","author":"AA Onitilo","year":"2009","unstructured":"Onitilo, A. A., et al. (2009). Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clinical Medicine & Research, 7(1\u20132), 4\u201313.","journal-title":"Clinical Medicine & Research"},{"issue":"12","key":"9415_CR26","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4161\/cc.9.12.12048","volume":"9","author":"UE Martinez-Outschoorn","year":"2010","unstructured":"Martinez-Outschoorn, U. E., et al. (2010). Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle, 9(12), 2423\u20132433.","journal-title":"Cell Cycle"},{"issue":"2","key":"9415_CR27","first-page":"550","volume":"61","author":"M Lohr","year":"2001","unstructured":"Lohr, M., et al. (2001). Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Research, 61(2), 550\u2013555.","journal-title":"Cancer Research"},{"issue":"16","key":"9415_CR28","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1073\/pnas.84.16.5763","volume":"84","author":"DA Bronzert","year":"1987","unstructured":"Bronzert, D. A., et al. (1987). Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America, 84(16), 5763\u20135767.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"38","key":"9415_CR29","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/sj.onc.1203785","volume":"19","author":"ZM Shao","year":"2000","unstructured":"Shao, Z. M., et al. (2000). Human breast carcinoma desmoplasia is PDGF initiated. Oncogene, 19(38), 4337\u20134345.","journal-title":"Oncogene"},{"issue":"4","key":"9415_CR30","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1523-1755.2000.00997.x","volume":"57","author":"F Strutz","year":"2000","unstructured":"Strutz, F., et al. (2000). Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney International, 57(4), 1521\u20131538.","journal-title":"Kidney International"},{"issue":"17","key":"9415_CR31","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1158\/0008-5472.CAN-10-0785","volume":"70","author":"E Giannoni","year":"2010","unstructured":"Giannoni, E., et al. (2010). Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial\u2013mesenchymal transition and cancer stemness. Cancer Research, 70(17), 6945\u20136956.","journal-title":"Cancer Research"},{"key":"9415_CR32","doi-asserted-by":"crossref","unstructured":"Hugo, H. J., et al. (2012). Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor microenvironment. Cancer Microenvironment. doi: 10.1007\/s12307-012-0098-7","DOI":"10.1007\/s12307-012-0098-7"},{"issue":"5","key":"9415_CR33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1073\/pnas.92.5.1381","volume":"92","author":"AJ Koleske","year":"1995","unstructured":"Koleske, A. J., et al. (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proceedings of the National Academy of Sciences of the United States of America, 92(5), 1381\u20131385.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"9415_CR34","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4161\/cc.9.16.12553","volume":"9","author":"UE Martinez-Outschoorn","year":"2010","unstructured":"Martinez-Outschoorn, U. E., et al. (2010). Oxidative stress in cancer associated fibroblasts drives tumor\u2013stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle, 9(16), 3256\u20133276.","journal-title":"Cell Cycle"},{"key":"9415_CR35","doi-asserted-by":"crossref","unstructured":"Al-Ansari, M. M., et al. (2012). p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts. Oncogene. doi: 10.1038\/onc.2012.270","DOI":"10.1038\/onc.2012.270"},{"issue":"6456","key":"9415_CR36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano, M., et al. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature, 366(6456), 704\u2013707.","journal-title":"Nature"},{"issue":"3\u20134","key":"9415_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2152\/jmi.51.146","volume":"51","author":"N Ohtani","year":"2004","unstructured":"Ohtani, N., et al. (2004). The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. The Journal of Medical Investigation, 51(3\u20134), 146\u2013153.","journal-title":"The Journal of Medical Investigation"},{"issue":"2","key":"9415_CR38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-004-7603-8","volume":"91","author":"E Matros","year":"2005","unstructured":"Matros, E., et al. (2005). BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Research and Treatment, 91(2), 179\u2013186.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"9415_CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/modpathol.3880310","volume":"14","author":"T Hasebe","year":"2001","unstructured":"Hasebe, T., et al. (2001). Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Modern Pathology, 14(4), 325\u2013337.","journal-title":"Modern Pathology"},{"issue":"3","key":"9415_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo, A., et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell, 121(3), 335\u2013348.","journal-title":"Cell"},{"issue":"7","key":"9415_CR41","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1158\/0008-5472.CAN-09-3644","volume":"70","author":"RA Saito","year":"2010","unstructured":"Saito, R. A., et al. (2010). Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Research, 70(7), 2644\u20132654.","journal-title":"Cancer Research"},{"issue":"12","key":"9415_CR42","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1158\/1078-0432.CCR-08-2824","volume":"15","author":"C Zhang","year":"2009","unstructured":"Zhang, C., et al. (2009). Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clinical Cancer Research, 15(12), 4017\u20134027.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"9415_CR43","first-page":"1320","volume":"61","author":"MP Shekhar","year":"2001","unstructured":"Shekhar, M. P., et al. (2001). Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Research, 61(4), 1320\u20131326.","journal-title":"Cancer Research"},{"issue":"1","key":"9415_CR44","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr949","volume":"7","author":"A Sadlonova","year":"2005","unstructured":"Sadlonova, A., et al. (2005). Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Research, 7(1), R46\u2013R59.","journal-title":"Breast Cancer Research"},{"issue":"2","key":"9415_CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01805840","volume":"11","author":"EF Adams","year":"1988","unstructured":"Adams, E. F., et al. (1988). Effects of human breast fibroblasts on growth and 17 beta-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Research and Treatment, 11(2), 165\u2013172.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"9415_CR46","doi-asserted-by":"crossref","first-page":"e9832","DOI":"10.1371\/journal.pone.0009832","volume":"5","author":"CH Stuelten","year":"2010","unstructured":"Stuelten, C. H., et al. (2010). Transient tumor\u2013fibroblast interactions increase tumor cell malignancy by a TGF-beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One, 5(3), e9832.","journal-title":"PLoS One"},{"issue":"9","key":"9415_CR47","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0813306106","volume":"106","author":"M Hu","year":"2009","unstructured":"Hu, M., et al. (2009). Role of COX-2 in epithelial\u2013stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proceedings of the National Academy of Sciences of the United States of America, 106(9), 3372\u20133377.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"9415_CR48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu, M., et al. (2008). Regulation of in situ to invasive breast carcinoma transition. Cancer Cell, 13(5), 394\u2013406.","journal-title":"Cancer Cell"},{"issue":"11","key":"9415_CR49","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","volume":"72","author":"A Tsuyada","year":"2012","unstructured":"Tsuyada, A., et al. (2012). CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Research, 72(11), 2768\u20132779.","journal-title":"Cancer Research"},{"issue":"7355","key":"9415_CR50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z., et al. (2011). CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature, 475(7355), 222\u2013225.","journal-title":"Nature"},{"issue":"7335","key":"9415_CR51","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature09707","volume":"470","author":"W Tan","year":"2011","unstructured":"Tan, W., et al. (2011). Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature, 470(7335), 548\u2013553.","journal-title":"Nature"},{"key":"9415_CR52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","volume":"18","author":"D Rossi","year":"2000","unstructured":"Rossi, D., et al. (2000). The biology of chemokines and their receptors. Annual Review of Immunology, 18, 217\u2013242.","journal-title":"Annual Review of Immunology"},{"issue":"16","key":"9415_CR53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman, G. D. (2004). Mechanisms of bone metastasis. The New England Journal of Medicine, 350(16), 1655\u20131664.","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"9415_CR54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jnci.2012.06.002","volume":"24","author":"HA Azim","year":"2012","unstructured":"Azim, H. A., et al. (2012). Bone metastasis in breast cancer: the story of RANK-ligand. Journal of the Egyptian National Cancer Institute, 24(3), 107\u2013114.","journal-title":"Journal of the Egyptian National Cancer Institute"},{"issue":"4","key":"9415_CR55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen, J., et al. (2011). CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell, 19(4), 541\u2013555.","journal-title":"Cancer Cell"},{"issue":"17","key":"9415_CR56","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1158\/0008-5472.CAN-08-4253","volume":"69","author":"I Campbell","year":"2009","unstructured":"Campbell, I., et al. (2009). Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. Cancer Research, 69(17), 6765\u20136768. discussion 6769.","journal-title":"Cancer Research"},{"issue":"8","key":"9415_CR57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng1596","volume":"37","author":"M Hu","year":"2005","unstructured":"Hu, M., et al. (2005). Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genetics, 37(8), 899\u2013905.","journal-title":"Nature Genetics"},{"issue":"1","key":"9415_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M., et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 6(1), 17\u201332.","journal-title":"Cancer Cell"},{"issue":"5","key":"9415_CR59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00432-010-0932-6","volume":"137","author":"A Enkelmann","year":"2011","unstructured":"Enkelmann, A., et al. (2011). Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. Journal of Cancer Research and Clinical Oncology, 137(5), 751\u2013759.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"9415_CR60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/0008-5472.CAN-05-2508","volume":"66","author":"H Fiegl","year":"2006","unstructured":"Fiegl, H., et al. (2006). Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2\/neu status in primary breast cancer. Cancer Research, 66(1), 29\u201333.","journal-title":"Cancer Research"},{"issue":"23","key":"9415_CR61","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1158\/0008-5472.CAN-08-1319","volume":"68","author":"L Jiang","year":"2008","unstructured":"Jiang, L., et al. (2008). Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Research, 68(23), 9900\u20139908.","journal-title":"Cancer Research"},{"issue":"9","key":"9415_CR62","doi-asserted-by":"crossref","first-page":"e43456","DOI":"10.1371\/journal.pone.0043456","volume":"7","author":"J Yu","year":"2012","unstructured":"Yu, J., et al. (2012). Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2\u2032-deoxycytidine. PLoS One, 7(9), e43456.","journal-title":"PLoS One"},{"issue":"1","key":"9415_CR63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1465-9921-13-74","volume":"13","author":"CM Robinson","year":"2012","unstructured":"Robinson, C. M., et al. (2012). Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Respiratory Research, 13(1), 74.","journal-title":"Respiratory Research"},{"issue":"2","key":"9415_CR64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mce.2010.02.035","volume":"321","author":"KC Knower","year":"2010","unstructured":"Knower, K. C., et al. (2010). Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts. Molecular and Cellular Endocrinology, 321(2), 123\u2013130.","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"4","key":"9415_CR65","doi-asserted-by":"crossref","first-page":"e35128","DOI":"10.1371\/journal.pone.0035128","volume":"7","author":"SW Tyan","year":"2012","unstructured":"Tyan, S. W., et al. (2012). Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change. PLoS One, 7(4), e35128.","journal-title":"PLoS One"},{"issue":"2","key":"9415_CR66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrm2621","volume":"10","author":"VK Gangaraju","year":"2009","unstructured":"Gangaraju, V. K., et al. (2009). MicroRNAs: key regulators of stem cells. Nature Reviews Molecular Cell Biology, 10(2), 116\u2013125.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"4","key":"9415_CR67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/cvr\/cvn151","volume":"79","author":"F Fazi","year":"2008","unstructured":"Fazi, F., et al. (2008). MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovascular Research, 79(4), 553\u2013561.","journal-title":"Cardiovascular Research"},{"key":"9415_CR68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1101\/sqb.2006.71.049","volume":"71","author":"AK Leung","year":"2006","unstructured":"Leung, A. K., et al. (2006). Function and localization of microRNAs in mammalian cells. Cold Spring Harbor Symposia on Quantitative Biology, 71, 29\u201338.","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"issue":"24","key":"9415_CR69","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1101\/gad.1982910","volume":"24","author":"G Tiscornia","year":"2010","unstructured":"Tiscornia, G., et al. (2010). MicroRNAs in embryonic stem cell function and fate. Genes & Development, 24(24), 2732\u20132741.","journal-title":"Genes & Development"},{"issue":"11","key":"9415_CR70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/1947601910396213","volume":"1","author":"BN Davis-Dusenbery","year":"2010","unstructured":"Davis-Dusenbery, B. N., et al. (2010). MicroRNA in cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer, 1(11), 1100\u20131114.","journal-title":"Genes Cancer"},{"issue":"13","key":"9415_CR71","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-11-0608","volume":"71","author":"TA Farazi","year":"2011","unstructured":"Farazi, T. A., et al. (2011). MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Research, 71(13), 4443\u20134453.","journal-title":"Cancer Research"},{"issue":"4","key":"9415_CR72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos, D., et al. (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell, 139(4), 693\u2013706.","journal-title":"Cell"},{"issue":"4","key":"9415_CR73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","volume":"39","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos, D., et al. (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular Cell, 39(4), 493\u2013506.","journal-title":"Molecular Cell"},{"issue":"16","key":"9415_CR74","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio, M. V., et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Research, 65(16), 7065\u20137070.","journal-title":"Cancer Research"},{"issue":"8","key":"9415_CR75","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/138945010791591403","volume":"11","author":"V Jazbutyte","year":"2010","unstructured":"Jazbutyte, V., et al. (2010). MicroRNA-21: from cancer to cardiovascular disease. Current Drug Targets, 11(8), 926\u2013935.","journal-title":"Current Drug Targets"},{"issue":"1","key":"9415_CR76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-008-0219-7","volume":"117","author":"B Qian","year":"2009","unstructured":"Qian, B., et al. (2009). High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Research and Treatment, 117(1), 131\u2013140.","journal-title":"Breast Cancer Research and Treatment"},{"key":"9415_CR77","doi-asserted-by":"crossref","unstructured":"Aprelikova, O., et al. (2012). Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene. doi: 10.1038\/onc.2012.351","DOI":"10.1038\/onc.2012.351"},{"issue":"21","key":"9415_CR78","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.4161\/cc.9.21.13674","volume":"9","author":"O Aprelikova","year":"2010","unstructured":"Aprelikova, O., et al. (2010). The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle, 9(21), 4387\u20134398.","journal-title":"Cell Cycle"},{"issue":"41","key":"9415_CR79","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/onc.2011.140","volume":"30","author":"M Musumeci","year":"2010","unstructured":"Musumeci, M., et al. (2010). Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene, 30(41), 4231\u20134242.","journal-title":"Oncogene"},{"issue":"10","key":"9415_CR80","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4161\/cbt.12.10.17780","volume":"12","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn, U. E., et al. (2011). Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biology & Therapy, 12(10), 924\u2013938.","journal-title":"Cancer Biology & Therapy"},{"key":"9415_CR81","doi-asserted-by":"crossref","unstructured":"Sun, Y., et al. (2012). Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine. doi: 10.1038\/nm.2890","DOI":"10.1038\/nm.2890"},{"key":"9415_CR82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-397927-8.00003-8","volume":"65","author":"J Tchou","year":"2012","unstructured":"Tchou, J., et al. (2012). Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm. Advances in Pharmacology, 65, 45\u201361.","journal-title":"Advances in Pharmacology"},{"issue":"9793","key":"9415_CR83","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"C Davies","year":"2011","unstructured":"Davies, C., et al. (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet, 378(9793), 771\u2013784.","journal-title":"Lancet"},{"issue":"5","key":"9415_CR84","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2353\/ajpath.2007.061004","volume":"170","author":"MP Shekhar","year":"2007","unstructured":"Shekhar, M. P., et al. (2007). Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. American Journal of Pathology, 170(5), 1546\u20131560.","journal-title":"American Journal of Pathology"},{"issue":"2","key":"9415_CR85","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-011-1766-x","volume":"133","author":"O Pontiggia","year":"2012","unstructured":"Pontiggia, O., et al. (2012). The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin. Breast Cancer Research and Treatment, 133(2), 459\u2013471.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"9415_CR86","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/bcr3224","volume":"14","author":"KL Mueller","year":"2012","unstructured":"Mueller, K. L., et al. (2012). Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Research, 14(4), R104.","journal-title":"Breast Cancer Research"},{"issue":"9","key":"9415_CR87","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/1541-7786.MCR-12-0030","volume":"10","author":"AC Johansson","year":"2012","unstructured":"Johansson, A. C., et al. (2012). Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Molecular Cancer Research, 10(9), 1158\u20131168.","journal-title":"Molecular Cancer Research"},{"issue":"3","key":"9415_CR88","first-page":"689","volume":"39","author":"A Dittmer","year":"2011","unstructured":"Dittmer, A., et al. (2011). Mesenchymal stem cells and carcinoma-associated fibroblasts sensitize breast cancer cells in 3D cultures to kinase inhibitors. International Journal of Oncology, 39(3), 689\u2013696.","journal-title":"International Journal of Oncology"},{"key":"9415_CR89","doi-asserted-by":"crossref","unstructured":"Capparelli, C., et al. (2012). CDK inhibitors (p16\/p19\/p21) induce senescence and autophagy in cancer-associated fibroblasts, \u201cfueling\u201d tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle, 11(19).","DOI":"10.4161\/cc.21884"},{"issue":"3","key":"9415_CR90","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.2278","volume":"214","author":"A Bergamaschi","year":"2008","unstructured":"Bergamaschi, A., et al. (2008). Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. The Journal of Pathology, 214(3), 357\u2013367.","journal-title":"The Journal of Pathology"},{"issue":"5","key":"9415_CR91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","volume":"14","author":"G Finak","year":"2008","unstructured":"Finak, G., et al. (2008). Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine, 14(5), 518\u2013527.","journal-title":"Nature Medicine"},{"issue":"6","key":"9415_CR92","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2353\/ajpath.2009.080924","volume":"174","author":"EK Sloan","year":"2009","unstructured":"Sloan, E. K., et al. (2009). Stromal cell expression of caveolin-1 predicts outcome in breast cancer. American Journal of Pathology, 174(6), 2035\u20132043.","journal-title":"American Journal of Pathology"},{"issue":"23","key":"9415_CR93","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides, S., et al. (2009). The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle, 8(23), 3984\u20134001.","journal-title":"Cell Cycle"},{"issue":"1","key":"9415_CR94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm.1908","volume":"15","author":"P Farmer","year":"2009","unstructured":"Farmer, P., et al. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine, 15(1), 68\u201374.","journal-title":"Nature Medicine"},{"key":"9415_CR95","doi-asserted-by":"crossref","unstructured":"Ahn, S., et al. (2012). The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biology, 33, 1573\u20131580.","DOI":"10.1007\/s13277-012-0411-6"},{"issue":"17","key":"9415_CR96","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","volume":"71","author":"L Martinet","year":"2011","unstructured":"Martinet, L., et al. (2011). Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Research, 71(17), 5678\u20135687.","journal-title":"Cancer Research"},{"issue":"1","key":"9415_CR97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo, D. G., et al. (2011). Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discovery, 1(1), 54\u201367.","journal-title":"Cancer Discovery"},{"issue":"7\u20139","key":"9415_CR98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1387\/ijdb.113371dl","volume":"55","author":"D Laoui","year":"2011","unstructured":"Laoui, D., et al. (2011). Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. International Journal of Developmental Biology, 55(7\u20139), 861\u2013867.","journal-title":"International Journal of Developmental Biology"},{"issue":"8","key":"9415_CR99","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jcp.50.8.669","volume":"50","author":"AH Lee","year":"1997","unstructured":"Lee, A. H., et al. (1997). Angiogenesis and inflammation in invasive carcinoma of the breast. Journal of Clinical Pathology, 50(8), 669\u2013673.","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"9415_CR100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10549-010-1154-y","volume":"128","author":"MJ Campbell","year":"2011","unstructured":"Campbell, M. J., et al. (2011). Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Research and Treatment, 128(3), 703\u2013711.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"20","key":"9415_CR101","first-page":"4625","volume":"56","author":"RD Leek","year":"1996","unstructured":"Leek, R. D., et al. (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research, 56(20), 4625\u20134629.","journal-title":"Cancer Research"},{"issue":"2","key":"9415_CR102","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis, C. E., et al. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Research, 66(2), 605\u2013612.","journal-title":"Cancer Research"},{"issue":"2","key":"9415_CR103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G","volume":"192","author":"JS Lewis","year":"2000","unstructured":"Lewis, J. S., et al. (2000). Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. The Journal of Pathology, 192(2), 150\u2013158.","journal-title":"The Journal of Pathology"},{"issue":"6","key":"9415_CR104","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1189\/jlb.0905495","volume":"80","author":"AE Dirkx","year":"2006","unstructured":"Dirkx, A. E., et al. (2006). Monocyte\/macrophage infiltration in tumors: modulators of angiogenesis. Journal of Leukocyte Biology, 80(6), 1183\u20131196.","journal-title":"Journal of Leukocyte Biology"},{"issue":"7","key":"9415_CR105","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/1535-7163.MCT-09-0280","volume":"8","author":"CL Roland","year":"2009","unstructured":"Roland, C. L., et al. (2009). Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Molecular Cancer Therapeutics, 8(7), 1761\u20131771.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"23","key":"9415_CR106","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1158\/0008-5472.CAN-07-1882","volume":"67","author":"C Melani","year":"2007","unstructured":"Melani, C., et al. (2007). Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Research, 67(23), 11438\u201311446.","journal-title":"Cancer Research"},{"issue":"6","key":"9415_CR107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin, E. Y., et al. (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. The Journal of Experimental Medicine, 193(6), 727\u2013740.","journal-title":"The Journal of Experimental Medicine"},{"issue":"2","key":"9415_CR108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1830","volume":"207","author":"SJ Oosterling","year":"2005","unstructured":"Oosterling, S. J., et al. (2005). Macrophages direct tumour histology and clinical outcome in a colon cancer model. The Journal of Pathology, 207(2), 147\u2013155.","journal-title":"The Journal of Pathology"},{"issue":"1","key":"9415_CR109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/erm.10.97","volume":"11","author":"RA Mukhtar","year":"2011","unstructured":"Mukhtar, R. A., et al. (2011). Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Review of Molecular Diagnostics, 11(1), 91\u2013100.","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"4","key":"9415_CR110","doi-asserted-by":"crossref","first-page":"e36051","DOI":"10.1371\/journal.pone.0036051","volume":"7","author":"S Nilsson","year":"2012","unstructured":"Nilsson, S., et al. (2012). Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One, 7(4), e36051.","journal-title":"PLoS One"},{"key":"9415_CR111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1476-4598-10-117","volume":"10","author":"M Yang","year":"2011","unstructured":"Yang, M., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular Cancer, 10, 117.","journal-title":"Molecular Cancer"},{"issue":"8","key":"9415_CR112","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1349-7006.2008.00880.x","volume":"99","author":"K Hiraoka","year":"2008","unstructured":"Hiraoka, K., et al. (2008). Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes\/macrophages. Cancer Science, 99(8), 1595\u20131602.","journal-title":"Cancer Science"},{"issue":"8","key":"9415_CR113","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.jid.5700827","volume":"127","author":"S Gazzaniga","year":"2007","unstructured":"Gazzaniga, S., et al. (2007). Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. The Journal of Investigative Dermatology, 127(8), 2031\u20132041.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"3","key":"9415_CR114","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","volume":"95","author":"SM Zeisberger","year":"2006","unstructured":"Zeisberger, S. M., et al. (2006). Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. British Journal of Cancer, 95(3), 272\u2013281.","journal-title":"British Journal of Cancer"},{"issue":"13","key":"9415_CR115","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-09-2904","volume":"16","author":"W Zhang","year":"2010","unstructured":"Zhang, W., et al. (2010). Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clinical Cancer Research, 16(13), 3420\u20133430.","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"9415_CR116","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjc.6605814","volume":"103","author":"JD Veltman","year":"2010","unstructured":"Veltman, J. D., et al. (2010). Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. British Journal of Cancer, 103(5), 629\u2013641.","journal-title":"British Journal of Cancer"},{"issue":"11","key":"9415_CR117","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1359\/jbmr.1998.13.11.1668","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman, S. P., et al. (1998). Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. Journal of Bone and Mineral Research, 13(11), 1668\u20131678.","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"9415_CR118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.5650020209","volume":"2","author":"MG Cecchini","year":"1987","unstructured":"Cecchini, M. G., et al. (1987). Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. Journal of Bone and Mineral Research, 2(2), 135\u2013142.","journal-title":"Journal of Bone and Mineral Research"},{"issue":"12","key":"9415_CR119","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1582-4934.2009.00926.x","volume":"14","author":"M Coscia","year":"2010","unstructured":"Coscia, M., et al. (2010). Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. Journal of Cellular and Molecular Medicine, 14(12), 2803\u20132815.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"9415_CR120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yexcr.2004.08.037","volume":"301","author":"YG Man","year":"2004","unstructured":"Man, Y. G., et al. (2004). The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the \u201cprotease-centered\u201d hypothesis. Experimental Cell Research, 301(2), 103\u2013118.","journal-title":"Experimental Cell Research"},{"issue":"1","key":"9415_CR121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.177.1.84","volume":"177","author":"KL Knutson","year":"2006","unstructured":"Knutson, K. L., et al. (2006). IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice. Journal of Immunology, 177(1), 84\u201391.","journal-title":"Journal of Immunology"},{"issue":"15","key":"9415_CR122","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud, S. M., et al. (2011). Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of Clinical Oncology, 29(15), 1949\u20131955.","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"9415_CR123","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1073\/pnas.1104303108","volume":"109","author":"B Ruffell","year":"2012","unstructured":"Ruffell, B., et al. (2012). Leukocyte composition of human breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 109(8), 2796\u20132801.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"9415_CR124","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2011","unstructured":"Acharyya, S., et al. (2011). A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell, 150(1), 165\u2013178.","journal-title":"Cell"},{"issue":"5","key":"9415_CR125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI23424","volume":"115","author":"P Iyengar","year":"2005","unstructured":"Iyengar, P., et al. (2005). Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor\/stroma microenvironment. The Journal of Clinical Investigation, 115(5), 1163\u20131176.","journal-title":"The Journal of Clinical Investigation"},{"issue":"41","key":"9415_CR126","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/sj.onc.1206737","volume":"22","author":"P Iyengar","year":"2003","unstructured":"Iyengar, P., et al. (2003). Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene, 22(41), 6408\u20136423.","journal-title":"Oncogene"},{"issue":"4","key":"9415_CR127","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.juro.2009.06.015","volume":"182","author":"DS Finley","year":"2009","unstructured":"Finley, D. S., et al. (2009). Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. Journal of Urology, 182(4), 1621\u20131627.","journal-title":"Journal of Urology"},{"issue":"3","key":"9415_CR128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/scd.2007.0181","volume":"17","author":"JM Yu","year":"2008","unstructured":"Yu, J. M., et al. (2008). Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells and Development, 17(3), 463\u2013473.","journal-title":"Stem Cells and Development"},{"issue":"30","key":"9415_CR129","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/onc.2009.130","volume":"28","author":"M Walter","year":"2009","unstructured":"Walter, M., et al. (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene, 28(30), 2745\u20132755.","journal-title":"Oncogene"},{"key":"9415_CR130","doi-asserted-by":"crossref","unstructured":"Welte, G., et al. (2012). Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion. Molecular Carcinogenesis, 51, 861\u2013868.","DOI":"10.1002\/mc.20854"},{"issue":"1","key":"9415_CR131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2009.04.013","volume":"284","author":"S Pinilla","year":"2009","unstructured":"Pinilla, S., et al. (2009). Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Letters, 284(1), 80\u201385.","journal-title":"Cancer Letters"},{"issue":"5","key":"9415_CR132","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ijc.26493","volume":"131","author":"E Devarajan","year":"2011","unstructured":"Devarajan, E., et al. (2011). Epithelial\u2013mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. International Journal of Cancer, 131(5), 1023\u20131031.","journal-title":"International Journal of Cancer"},{"issue":"4","key":"9415_CR133","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/carcin\/bgp036","volume":"30","author":"FL Muehlberg","year":"2009","unstructured":"Muehlberg, F. L., et al. (2009). Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 30(4), 589\u2013597.","journal-title":"Carcinogenesis"},{"issue":"1","key":"9415_CR134","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2011.06.101","volume":"411","author":"L Bochet","year":"2011","unstructured":"Bochet, L., et al. (2011). Cancer-associated adipocytes promotes breast tumor radioresistance. Biochemical and Biophysical Research Communications, 411(1), 102\u2013106.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"9415_CR135","first-page":"994","volume":"25","author":"J Ligibel","year":"2011","unstructured":"Ligibel, J. (2011). Obesity and breast cancer. Oncology (Williston Park, N.Y.), 25(11), 994\u20131000.","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"9415_CR136","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000316896","volume":"19","author":"B Dirat","year":"2010","unstructured":"Dirat, B., et al. (2010). Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocrine Development, 19, 45\u201352.","journal-title":"Endocrine Development"},{"issue":"2","key":"9415_CR137","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10787-009-8049-8","volume":"17","author":"RE Harris","year":"2009","unstructured":"Harris, R. E., et al. (2009). Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology, 17(2), 55\u201367.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"9415_CR138","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1078-0432.CCR-10-2507","volume":"18","author":"WC Dougall","year":"2012","unstructured":"Dougall, W. C., et al. (2012). Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL\/RANK\/OPG pathway in tumorigenesis and metastasis. Clinical Cancer Research, 18(2), 326\u2013335.","journal-title":"Clinical Cancer Research"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-012-9415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-012-9415-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-012-9415-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:20:10Z","timestamp":1559222410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-012-9415-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":138,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9415"],"URL":"https:\/\/doi.org\/10.1007\/s10555-012-9415-3","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}